Financhill
Sell
47

BEAM Quote, Financials, Valuation and Earnings

Last price:
$26.38
Seasonality move :
-20.08%
Day range:
$25.59 - $27.05
52-week range:
$20.84 - $49.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.18x
P/B ratio:
2.76x
Volume:
1.6M
Avg. volume:
1.1M
1-year change:
-2.55%
Market cap:
$2.2B
Revenue:
$377.7M
EPS (TTM):
-$1.76

Earnings Data

Next earnings date for BEAM
Feb 27
2025
Most recent earnings per share
-$1.17
Beat by $0.01
(Nov 5/2024)
Consensus Estimate
-$1.18
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BEAM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $15.2M -- -- -$1.25 --
02/27/2025 Q4 $16.5M -- -- -$1.25 --
11/05/2024 Q3 $14.1M $14.3M -$1.17 -$1.18 $0.01
08/06/2024 Q2 $13M $11.8M -$1.11 -$1.12 $0.01
05/07/2024 Q1 $14.7M $7.4M -$1.21 -$1.39 $0.18
02/27/2024 Q4 $33.7M $316.2M $1.73 -$0.71 $2.44
11/08/2023 Q3 -- -- -$1.22 -$1.27 $0.05
08/08/2023 Q2 -- -- -$1.08 -$1.38 $0.30
05/10/2023 Q1 -- -- -$1.33 -$1.30 -$0.03
02/28/2023 Q4 -- -- -$0.54 -$1.34 $0.80
11/07/2022 Q3 -- -- -$1.56 -$1.09 -$0.47
08/09/2022 Q2 -- -- -$1.02 -$1.02 $0.00
05/09/2022 Q1 -- -- -$1.01 -$1.34 $0.33
02/28/2022 Q4 -- -- -$0.95 -$0.94 -$0.01
11/08/2021 Q3 -- -- -$0.42 -$0.72 $0.30
08/10/2021 Q2 -- -- -$1.23 -$0.74 -$0.49
05/11/2021 Q1 -- -- -$3.35 -$0.75 -$2.60
03/30/2021 Q4 -- -- -$1.88 -$0.68 -$1.20
11/10/2020 Q3 -- -- -$0.69 -$0.54 -$0.15
08/12/2020 Q2 -- -- -$0.69 -$0.51 -$0.18
05/12/2020 Q1 -- -- -$1.03 -$0.48 -$0.55
03/30/2020 Q4 -- -- -$0.69 -$0.49 -$0.20
09/30/2019 Q3 -- -- -$0.63 -- --
06/30/2019 Q2 -- -- -$0.60 -- --
03/31/2019 Q1 -- -- -$0.47 -- --
12/31/2018 Q4 -- -- -$0.75 -- --
09/30/2018 Q3 -- -- -$2.00 -- --

Beam Therapeutics Earnings Questions

  • How Much did Beam Therapeutics Generate in Revenue Last Quarter?

    Beam Therapeutics reported $14.3M worth of top line sales in its most recent quarter.

  • Did Beam Therapeutics Beat Earnings Last Quarter?

    Beam Therapeutics announced earnings per share of -$1.17 which represents a beat of analyst forecast a -$1.18 per share.

  • Is Beam Therapeutics Profitable?

    Beam Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Beam Therapeutics EPS Next Year?

    Beam Therapeutics's earnings are forecast to decrease from -$1.72 per share to -$4.71 per share next year representing a decrease of -175.47%.

  • When is Beam Therapeutics's Earnings Date?

    Beam Therapeutics's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock